Myriad Genetics Inc 's (MYGN) Outlook - CSIMarket
CSIMarket
 
Myriad Genetics Inc   (NASDAQ: MYGN)
 



  Myriad Genetics Inc Outlook

On January 15 2025 the Myriad Genetics Inc provided following guidance

Myriad Genetics Inc. has recently released select preliminary financial results for the fourth quarter and the entirety of the fiscal year 2024. In conjunction with these results, the company has also outlined its financial expectations for the full year 2025. While specific figures regarding the 2025 financial guidance have yet to be disclosed, the announcement marks a noteworthy moment for the company as it provides insights into its anticipated performance in the upcoming year. More detailed information pertaining to the financial outlook for 2025 is expected to be shared in future communications.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.